European Journal of Cancer
Volume 41, Issue 11 , Pages 1547-1550, July 2005

A phase II trial with RFS2000 (rubitecan) in patients with advanced non-small cell lung cancer

  • S. Baka

      Affiliations

    • Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 161 446 3126; fax: +44 161 446 3299.
    • ,
  • M. Ranson

      Affiliations

    • Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK
    • ,
  • P. Lorigan

      Affiliations

    • Department of Medical Oncology, Weston Park Hospital, Sheffield, UK
    • ,
  • S. Danson

      Affiliations

    • Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK
    • ,
  • K. Linton

      Affiliations

    • Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK
    • ,
  • I. Hoogendam

      Affiliations

    • NDDO Representative, UK
    • ,
  • K. Mettinger

      Affiliations

    • Supergen Representative, UK
    • ,
  • N. Thatcher

      Affiliations

    • Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK

Received 10 November 2004; received in revised form 23 February 2005; accepted 1 March 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(05)00217-0

doi:10.1016/j.ejca.2005.03.009

European Journal of Cancer
Volume 41, Issue 11 , Pages 1547-1550, July 2005

Article Tools